GPT-Rosalind: OpenAI Launches Specialized AI for Life Sciences
On April 16, OpenAI launched GPT-Rosalind, a frontier reasoning model purpose-built for drug discovery, genomics, and protein engineering — named after pioneering chemist Rosalind Franklin. Fine-tuned across genomics, protein engineering, and chemistry, it achieved leading BixBench performance and outperformed GPT-5.4 on 6 of 11 LABBench2 tasks. Enterprise customers include Amgen, Moderna, Allen Institute, and Thermo Fisher.